Grace Therapeutics, Inc. (GRCE)
Free Cash Flow Growth
21.42%
TTM · Period ending:
GRCE Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported21.42%period ending
Latest reported21.42%period ending
GRCE TTM Free Cash Flow YoY % (-0.58% → 21.42%)
Year-over-year change
High-resolution chart · PNG
GRCE free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 21.4232% | |
| 40.4144% | |
| 27.9659% | |
| -1.5852% | |
| -34.9912% | |
| -20.6313% | |
| -3.5422% | |
| 23.1813% | |
| 41.9788% | |
| 22.4419% | |
| 13.7348% | |
| 7.1915% | |
| 13.1268% | |
| 11.6921% | |
| 7.9751% | |
| 7.2558% | |
| -10.7172% | |
| 4.5446% | |
| 15.6753% | |
| 19.5856% | |
| 23.7728% | |
| 21.1528% | |
| 28.6326% | |
| 21.9347% | |
| 17.3405% | |
| 5.1632% | |
| -38.5195% | |
| -70.578% | |
| -109.4941% | |
| -152.1254% | |
| -138.6205% | |
| -175.9238% | |
| -109.0157% | |
| -38.5009% | |
| -7.3086% | |
| -0.0544% | |
| -8.5258% | |
| 11.3941% | |
| 0.645% | |
| 12.3414% | |
| 31.7049% | |
| 12.4206% | |
| -9.1053% | |
| 5.4772% | |
| -314.807% | |
| -315.6338% | |
| -102.7374% | |
| -144.5558% | |
| 50.2109% | |
| 73.722% | |
| 51.4663% | |
| 54.9852% | |
| 11.177% | |
| -155.0107% | |
| -166.5365% | |
| -195.7318% | |
| -134.6089% | |
| -102.2506% | |
| -77.6212% | |
| -0.5805% |